References 583 & 522. Pfaehler E, van Sluis J, Merema BBJ, van Ooijen P, Berendsen RCM, van Velden FHP, et al. Experimental Multicenter and Multivendor Evaluation of the Performance of PET Radiomic Features Using 3-Dimensionally Printed Phantom Inserts. Journal of nuclear medicine. 2020;61:469-476. https://doi.org/10.2967/jnumed.119.229724. 523. Zwanenburg A, Vallières M, Abdalah MA, Aerts HJWL, Andrearczyk V, Apte A, et al. The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping. Radiology. 2020:191145. https://doi.org/10.1148/radiol.2020191145. 524. Orlhac F, Boughdad S, Philippe C, Stalla-Bourdillon H, Nioche C, Champion L, et al. A Postreconstruction Harmonization Method for Multicenter Radiomic Studies in PET. Journal of nuclear medicine. 2018;59:1321-1328. https://doi.org/10.2967/jnumed.117.199935. 525. Aydemirli MD, Snel M, van Wezel T, Ruano D, Obbink CMH, van den Hout WB, et al. Yield and costs of molecular diagnostics on thyroid cytology slides in the Netherlands, adapting the Bethesda classification. Endocrinol Diabetes Metab. 2021;4:e00293. https://doi.org/10.1002/edm2.293. 526. Husson O, Haak HR, Oranje WA, Mols F, Reemst PH, van de Poll-Franse LV. Health-related quality of life among thyroid cancer survivors: a systematic review. Clinical endocrinology. 2011;75:544–554. https://doi.org/10.1111/ j.1365-2265.2011.04114.x. 527. Statistics Netherlands. CBS Life tables and survival analyses. 2021. https://www.cbs.nl. 528. Lee S, Skelton TS, Zheng F, Schwartz KA, Perrier ND, Lee JE, et al. The biopsy-proven benign thyroid nodule: is longterm follow-up necessary? Journal of the American College of Surgeons. 2013;217:81-88; discussion 88-89. https:// doi.org/10.1016/j.jamcollsurg.2013.03.014. 529. Ajmal S, Rapoport S, Ramirez Batlle H, Mazzaglia PJ. The natural history of the benign thyroid nodule: what is the appropriate follow-up strategy? Journal of the American College of Surgeons. 2015;220:987-992. https://doi. org/10.1016/j.jamcollsurg.2014.12.010. 530. Nou E, Kwong N, Alexander LK, Cibas ES, Marqusee E, Alexander EK. Determination of the optimal time interval for repeat evaluation after a benign thyroid nodule aspiration. The Journal of clinical endocrinology and metabolism. 2014;99:510-516. https://doi.org/10.1210/jc.2013-3160. 531. Singh Ospina N, Maraka S, Espinosa de Ycaza AE, Brito JP, Castro MR, Morris JC, et al. Prognosis of patients with benign thyroid nodules: a population-based study. Endocrine. 2016;54:148-155. https://doi.org/10.1007/s12020016-0967-9. 532. Durante C, Costante G, Lucisano G, Bruno R, Meringolo D, Paciaroni A, et al. The natural history of benign thyroid nodules. JAMA. 2015;313:926-935. https://doi.org/10.1001/jama.2015.0956. 533. Lopez-Penabad L, Chiu AC, Hoff AO, Schultz P, Gaztambide S, Ordonez NG, et al. Prognostic factors in patients with Hurthle cell neoplasms of the thyroid. Cancer. 2003;97:1186-1194. https://doi.org/10.1002/cncr.11176. 534. Matsuzu K, Sugino K, Masudo K, Nagahama M, Kitagawa W, Shibuya H, et al. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases. World journal of surgery. 2014;38:68-79. https://doi.org/10.1007/ s00268-013-2224-1. 535. Nixon IJ, Ganly I, Patel SG, Palmer FL, Whitcher MM, Tuttle RM, et al. Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy. Surgery. 2012;151:571-579. https://doi.org/10.1016/j.surg.2011.08.016. 536. Sugino K, Kameyama K, Ito K, Nagahama M, Kitagawa W, Shibuya H, et al. Outcomes and prognostic factors of 251 patients with minimally invasive follicular thyroid carcinoma. Thyroid. 2012;22:798-804. https://doi.org/10.1089/ thy.2012.0051. 537. Thompson LD, Wieneke JA, Paal E, Frommelt RA, Adair CF, Heffess CS. A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer. 2001;91:505-524. https://doi. org/10.1002/1097-0142(20010201)91:3<505::aid-cncr1029>3.0.co;2-6. 538. D’Avanzo A, Treseler P, Ituarte PH, Wong M, Streja L, Greenspan FS, et al. Follicular thyroid carcinoma: histology and prognosis. Cancer. 2004;100:1123-1129. https://doi.org/10.1002/cncr.20081. 539. Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS, et al. Extent of surgery affects survival for papillary thyroid cancer. Annals of surgery. 2007;246:375-381; discussion 381-374. https://doi.org/10.1097/ SLA.0b013e31814697d9. 540. Bojoga A, Koot A, Bonenkamp J, de Wilt J, IntHout J, Stalmeier P, et al. The Impact of the Extent of Surgery on the LongTerm Outcomes of Patients with Low-Risk Differentiated Non-Medullary Thyroid Cancer: A Systematic Meta-Analysis. J Clin Med. 2020;9. https://doi.org/10.3390/jcm9072316. 541. Chan S, Karamali K, Kolodziejczyk A, Oikonomou G, Watkinson J, Paleri V, et al. Systematic Review of Recurrence Rate after Hemithyroidectomy for Low-Risk Well-Differentiated Thyroid Cancer. Eur Thyroid J. 2020;9:73-84. https://doi. org/10.1159/000504961. 542. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. The American journal of medicine. 1994;97:418-428. https://doi.org/10.1016/0002-9343(94)90321-2.
RkJQdWJsaXNoZXIy MTk4NDMw